Zentalis Pharmaceuticals (ZNTL) Stock Price, Quote, News & History | Benzinga

SPY779.87+0.10%QQQ759.84+0.02%BTC/USD84,286.73−1.47%DIA514.66+0.02%GLD381.90−0.10%TLT77.20−0.10%

Zentalis Pharmaceuticals Inc (ZNTL) Stock Price, Quote, News & History

ZNTLNASDAQ

Trade with Public

Trade with Public

$2.67

-0.11-3.96%

Last update: Oct 6, 7:07 PM

$2.68

-0.1-3.6%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$2.81

Close

$2.67

Volume / Avg.

827.90K / 1.20M

Day Range

$2.65 - $2.82

52 Wk Range

1.21 - 6.95

Market Cap

$253.72M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

33

Short Interest

5.96%

Days to Cover

5.24

Recent Zentalis Pharmaceuticals, Inc. News

This Small Biotech’s Cancer Drug Could Reach $1.3 Billion In Peak Sales

William Blair initiates Zentalis (ZNTL) at Outperform, citing a $1.3B peak sales potential for lead cancer drug azenosertib.

Vandana Singh

Why Webull Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Webull Corp (NASDAQ: BULL) rose sharply in pre-market trading after reporting better-than-expected Q2 results. Revenue of $198.83M beat estimates, while adjusted EPS of $0.05 also beat.

Avi Kapoor

ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Moving Higher On Friday

US stocks lower, Nasdaq falls 400 pts. ManpowerGroup shares rise after upbeat earnings. Other big gainers: PHOE, SG, TRVI, DCBO, ZNTL, GPRE, SLS, FEIM, TRV, BHVN, KOS, BJRI, MBX.

Avi Kapoor

Nasdaq Moves Higher; US Inflation Rate Accelerates In March

U.S. stocks mixed, Nasdaq up 100 points. Inflation rate surges to 3.3%. Japan's Nikkei 225 and China's Shanghai Composite close higher.

Avi Kapoor

What's Behind The Surge In Zentalis Stock?

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) shares are surging Friday after a Guggenheim analyst raised the price target from $6 to $10.

Alex Perry

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-128.10M

Investing Cash Flow (TTM)

120.81M

Financing Cash Flow (TTM)

-5.53M

Free Cash Flow (TTM)

-128.13M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-12.82M

Analyst Trends and Forecast

1

Apr

2

Jul

1

Sep

1

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.3

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$110.78M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

1.75

Earnings Yield % (TTM)

-73.68%

Earnings Yield % (FWD)

-91.17%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.52

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$24.78M

Debt to Equity

0.23

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-